-
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trial. EuroIntervention (IF 6.2) Pub Date : 2023-12-04 Alexandra J Lansky,Bo Xu,Andreas Baumbach,Henning Kelbæk,Niels van Royen,Ming Zheng,Paul Knaapen,Ton Slagboom,Thomas W Johnson,Georgios J Vlachojannis,Karin E Arkenbout,Lene Holmvang,Luc Janssens,Salvatore Brugaletta,Christoph K Naber,Thomas Schmitz,Richard Anderson,Harald Rittger,Sergio Berti,Emanuele Barbato,Gabor G Toth,Luc Maillard,Christian M Valina,Paweł E Buszman,Holger Thiele,Volker Schächinger
BACKGROUND In the prospective, multicentre, randomised TARGET All Comers study, percutaneous coronary intervention (PCI) with the FIREHAWK biodegradable-polymer sirolimus-eluting stent (BP-SES) was non-inferior to the durable-polymer everolimus-eluting stent (DP-EES) for the primary endpoint of target lesion failure (TLF) at 12 months. AIMS We aimed to report the final study outcomes at 5 years. METHODS
-
Changes in post-PCI physiology based on anatomical vessel location: a DEFINE PCI substudy. EuroIntervention (IF 6.2) Pub Date : 2023-11-30 Mitsuaki Matsumura,Akiko Maehara,Justin E Davis,Gautam Kumar,Andrew Sharp,Habib Samady,Arnold H Seto,David Cohen,Manesh R Patel,Ziad A Ali,Gregg W Stone,Allen Jeremias
BACKGROUND Anatomical vessel location affects post-percutaneous coronary intervention (PCI) physiology. AIMS We aimed to compare the post-PCI instantaneous wave-free ratio (iFR) in left anterior descending (LAD) versus non-LAD vessels and to identify the factors associated with a suboptimal post-PCI iFR. METHODS DEFINE PCI was a multicentre, prospective, observational study in which a blinded post-PCI
-
Long-term clinical outcomes of robotic-assisted surgical coronary artery revascularisation. EuroIntervention (IF 6.2) Pub Date : 2023-11-23 Aleksander Dokollari,Serge Sicouri,Ozgun Erten,William A Gray,Timothy A Shapiro,Frank McGeehin,Marwan Badri,Paul Coady,Eric Gnall,Mara Caroline,Amid A Khan,Stephanie Kjelstrom,Georgia Montone,Basel Ramlawi,Mary Ann Wertan,Francis P Sutter,Gianluca Torregrossa
BACKGROUND Patients who are not candidates for traditional coronary artery bypass grafting (CABG) and amenable only for percutaneous coronary intervention (PCI) with stents can receive the "gold standard" left internal thoracic artery (LITA) to left anterior descending artery (LAD) anastomosis through robotic-assisted CABG and PCI to non-LAD coronary targets. AIMS We aimed to analyse clinical outcomes
-
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI. EuroIntervention (IF 6.2) Pub Date : 2023-11-19 Roberto Scarsini,Emanuele Gallinoro,Marco B Ancona,Leonardo Portolan,Pasquale Paolisso,Paolo Springhetti,Francesco Della Mora,Andrea Mainardi,Marta Belmonte,Francesco Moroni,Luca A Ferri,Barbara Bellini,Filippo Russo,Ciro Vella,Dario Tino Bertolone,Gabriele Pesarini,Giovanni Benfari,Marc Vanderheyden,Matteo Montorfano,Bernard De Bruyne,Emanuele Barbato,Flavio Ribichini
BACKGROUND Microvascular resistance reserve (MRR) is a validated measure of coronary microvascular function independent of epicardial resistances. AIMS We sought to assess whether MRR is associated with adverse cardiac remodelling, a low-flow phenotype and extravalvular cardiac damage (EVCD) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). METHODS
-
One-year clinical outcomes of transcatheter aortic valve implantation with the latest iteration of self-expanding or balloonexpandable devices: insights from the OPERA-TAVI registry. EuroIntervention (IF 6.2) Pub Date : 2023-11-19 Giuliano Costa,Francesco Saia,Thomas Pilgrim,Mohamed Abdel-Wahab,Philippe Garot,Sofia Sammartino,Caterina Gandolfo,Luca Branca,Azeem Latib,Ignacio Amat-Santos,Darren Mylotte,Federico De Marco,Ole De Backer,Luis Nombela Franco,Mariama Akodad,Flavio Luciano Ribichini,Francesco Bedogni,Alessandro Mazzapicchi,Daijiro Tomii,Pietro Laforgia,Stefano Cannata,Claudia Fiorina,Andrea Scotti,Simone Fezzi,Enrico
BACKGROUND Midterm comparative analyses of the latest iterations of the most used Evolut and SAPIEN platforms for transcatheter aortic valve implantation (TAVI) are lacking. AIMS We aimed to compare 1-year clinical outcomes of TAVI patients receiving Evolut PRO/PRO+ (PRO) or SAPIEN 3 Ultra (ULTRA) devices in current real-world practice. METHODS Among patients enrolled in the OPERA-TAVI registry, patients
-
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study. EuroIntervention (IF 6.2) Pub Date : 2023-11-19 Liesbeth Rosseel,Nicholas J Montarello,Philippe Nuyens,Gabriella Tirado-Conte,Angelo Quagliana,Kristoff Cornelis,Vincent Floré,Michael Rosseel,Gintautas Bieliauskas,Lars Sondergaard,Ole De Backer
BACKGROUND Despite transcatheter aortic valve implantation (TAVI) having become a routine procedure, access site bleeding and vascular complications are still a concern which contribute to procedure-related morbidity and mortality. AIMS The TAVI-MultiCLOSE study aimed to assess the safety and efficacy of a new vascular closure algorithm for percutaneous large-bore arterial access closure following
-
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study. EuroIntervention (IF 6.2) Pub Date : 2023-11-19 Won-Keun Kim,Helge Möllmann,Matteo Montorfano,Julia Ellert-Gregersen,Tanja K Rudolph,Nicolas M Van Mieghem,Michael Hilker,Ignacio Amat-Santos,Christian Juhl Terkelsen,Anna Sonia Petronio,Pieter Stella,Matthias Götberg,Andreas Rück,A Markus Kasel,Ramiro Trillo,Clare Appleby,Marco Barbanti,Philipp Blanke,Federico M Asch,Rodrigo Modolo,Dominic J Allocco,Corrado Tamburino
BACKGROUND Transcatheter aortic valve implantation is an effective treatment for patients with aortic stenosis; however, complications related to paravalvular leakage (PVL) persist, including increased risk of mortality, cardiovascular mortality, and rehospitalisation. AIMS We sought to evaluate the clinical outcomes and valve performance at 1 year in patients with severe aortic stenosis treated with
-
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Piotr Pruszczyk,Grzegorz Kopeć
-
Patient-prosthesis mismatch following TAVR: time will tell. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Vinod H Thourani,Kimberly A Holst
-
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Francesco Maisano,Nicolo Piazza,Bernard Prendergast,Simon Redwood,Didier Tchétché,Nina C Wunderlich,Pcr London Valves Course Directors
-
Transcatheter mitral valve implantation for native valve disease. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Marina Urena,Philipp Lurz,Paul Sorajja,Dominique Himbert,Mayra Guerrero
Mitral regurgitation is the second most frequent heart valve disease in Europe and the most frequent in the US. Although surgery is the therapy of choice when intervention is indicated, transcatheter mitral valve repair or replacement are alternatives for patients who are not eligible for surgery. However, the development of transcatheter mitral valves is slower than expected. Although several transcatheter
-
Transcatheter tricuspid interventions are performed too late: pros and cons. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Marianna Adamo,Crina Ioana Radulescu,Shahrukh N Bakar,Neil P Fam
-
Redo-TAVI with a balloon-expandable valve and the impact of index transcatheter aortic valve design. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Ole De Backer,Janarthanan Sathananthan,Uri Landes,Haim D Danenberg,John Webb,Lars Sondergaard
-
Do we need another device for catheter interventional closure of septum secundum atrial septal defects? EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Peter Ewert,Andreas Eicken
-
Electrosurgical laceration and stabilisation of three clip devices (ELASTA-Clip) to enable transcatheter mitral valve implantation. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Jonathan Curio,Elmar W Kuhn,Maria Isabel Körber,Stephan Baldus,Jaffar M Khan,Matti Adam
-
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Kerstin Piayda,Mani Arsalan,Peter Roth,Oliver Dörr,Christian Hamm,Holger Nef,Andreas Böning
-
Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI. EuroIntervention (IF 6.2) Pub Date : 2023-11-14 Nozomi Kotoku,Kai Ninomiya,Shinichiro Masuda,Neil O'Leary,Scot Garg,Mareka Naito,Kotaro Miyashita,Akihiro Tobe,Shigetaka Kageyama,Tsung Ying Tsai,Pruthvi C Revaiah,Shengxian Tu,Ken Kozuma,Hideyuki Kawashima,Yuki Ishibashi,Gaku Nakazawa,Kuniaki Takahashi,Takayuki Okamura,Yosuke Miyazaki,Hiroki Tateishi,Masato Nakamura,Norihiro Kogame,Taku Asano,Shimpei Nakatani,Yoshihiro Morino,Masaru Ishida,Yuki Katagiri
BACKGROUND Even with intracoronary imaging-guided stent optimisation, suboptimal haemodynamic outcomes post-percutaneous coronary intervention (PCI) can be related to residual lesions in non-stented segments. Preprocedural assessment of pathophysiological coronary artery disease (CAD) patterns could help predict the physiological response to PCI. AIMS The aim of this study was to assess the relationship
-
Impact of extra-mitral valve cardiac involvement in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair. EuroIntervention (IF 6.2) Pub Date : 2023-11-09 Antonio Popolo Rubbio,Antonio Sisinni,Alice Moroni,Marianna Adamo,Carmelo Grasso,Matteo Casenghi,Maurizio B Tusa,Marta Barletta,Paolo Denti,Arturo Giordano,Federico De Marco,Antonio L Bartorelli,Matteo Montorfano,Cosmo Godino,Eustachio Agricola,Rodolfo Citro,Francesco De Felice,Annalisa Mongiardo,Ida Monteforte,Emmanuel Villa,Anna Sonia Petronio,Cristina Giannini,Gabriele Crimi,Giulia Masiero,Giuseppe
BACKGROUND In the context of primary mitral regurgitation (PMR), the selection of patients for transcatheter edge-to-edge repair (TEER) does not include a systematic assessment of PMR-associated cardiac remodelling. AIMS We aimed to investigate the epidemiology and prognostic significance of different phenotypes of extra-mitral valve (MV) cardiac involvement in a large series of patients with PMR referred
-
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI. EuroIntervention (IF 6.2) Pub Date : 2023-12-04 Masaaki Nakase,Taishi Okuno,Daijiro Tomii,Bashir Alaour,Fabien Praz,Stefan Stortecky,Jonas Lanz,David Reineke,Stephan Windecker,Thomas Pilgrim
BACKGROUND The prognostic value of cardiac damage staging classifications across the haemodynamic spectrum of severe aortic stenosis (AS) remains unknown. AIMS We aimed to investigate the prognostic impact of cardiac damage staging classifications in patients with high-gradient AS (HG-AS) and low-gradient AS (LG-AS) undergoing transcatheter aortic valve implantation (TAVI). METHODS In a prospective
-
Deformation of transcatheter heart valves with mitral valve-in-valve. EuroIntervention (IF 6.2) Pub Date : 2023-10-30 Miho Fukui,Atsushi Okada,Marcus R Burns,Hirotomo Sato,Kiahltone R Thao,Cheng Wang,Hideki Koike,Nadira Hamid,Maurice Enriquez-Sarano,John R Lesser,Joao L Cavalcante,Paul Sorajja,Vinayak N Bapat
BACKGROUND The use of oversizing in mitral valve-in-valve (MViV) procedures can lead to non-uniform expansion of transcatheter heart valves (THV). This may have implications for THV durability. AIMS The objective of this study was to assess the extent and predictors of THV deformation in MViV procedures. METHODS We examined 33 patients who underwent MViV with SAPIEN prostheses. The extent of THV deformation
-
TAVI in a patient with a double-lumen aortic arch. EuroIntervention (IF 6.2) Pub Date : 2023-10-26 Konstantinos Tsioufis,Kyriakos Dimitriadis,Konstantinos Aznaouridis,Konstantina Aggeli
-
Pulmonary artery denervation - the suspense continues? EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Felix Mahfoud,Felix Götzinger
-
The quest to refine atrial fibrillation-related stroke risk stratification: could the answer lie in left atrial appendage angiography? EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Gregory Y H Lip,Mark T Mills,Dhiraj Gupta
-
Reviewing scientific manuscripts in 2023: is it (still) worth the time? EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Nicolas Amabile,Giulio Stefanini
-
Consider aspirin bridging for non-cardiac surgery in patients with coronary stents treated with oral anticoagulation monotherapy. EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Troels Thim,Michael Maeng,Steen Dalby Kristensen
-
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial. EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Moritz Seiffert,Reinhard Vonthein,Helmut Baumgartner,Michael A Borger,Yeong-Hoon Choi,Volkmar Falk,Norbert Frey,Andreas Hagendorff,Christian Hagl,Christian Hamm,Inke R König,Ulf Landmesser,Steffen Massberg,Hermann Reichenspurner,Holger Thiele,Raphael Twerenbold,Maren Vens,Thomas Walther,Andreas Ziegler,Jochen Cremer,Stefan Blankenberg
Transcatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data
-
Transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the Association for Acute Cardiovascular Care (ACVC) and the ESC Working Group on Cardiovascular Surgery. EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Chiara Fraccaro,Nicole Karam,Helge Möllmann,Sabine Bleiziffer,Nikolaos Bonaros,Rui Campante Teles,Pedro Carrilho Ferreira,Alaide Chieffo,Martin Czerny,Erwan Donal,Dariusz Dudek,Nicolas Dumonteil,Giovanni Esposito,Stephane Fournier,Christian Hassager,Won-Keun Kim,Konstantin A Krychtiuk,Julinda Mehilli,Jerzy Pręgowski,Giulio G Stefanini,Julien Ternacle,Holger Thiele,Matthias Thielmann,Flavien Vincent
Valvular heart disease (VHD) is one of the most frequent causes of heart failure (HF) and is associated with poor prognosis, particularly among patients with conservative management. The development and improvement of catheter-based VHD interventions have broadened the indications for transcatheter valve interventions from inoperable/high-risk patients to younger/lower-risk patients. Cardiogenic shock
-
Left atrial appendage angiography for stroke risk prediction in patients with atrial fibrillation. EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Lisheng Jiang,Ziyong Hao,Xiaoyi Xie,Ke Xu,Lan Shen,Xin Pan,Cheng Wang,Lan Ma,Linghong Shen,Yiting Fan,Ben He
BACKGROUND The current risk stratification schemes for stroke in patients with atrial fibrillation (AF) are insufficient for an accurate assessment of stroke risk. AIMS This study evaluates the association between the mechanical function of the left atrial appendage (LAA), as assessed by angiography, and the risk of stroke. METHODS We conducted a cross-sectional study to assess the mechanical function
-
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial. EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Lars Jakobsen,Evald H Christiansen,Phillip Freeman,Johnny Kahlert,Karsten Veien,Michael Maeng,Bent Raungaard,Julia Ellert,Anton B Villadsen,Steen D Kristensen,Martin K Christensen,Christian J Terkelsen,Jens Aaroe,Troels Thim,Jens Flensted Lassen,Mikkel Hougaard,Ashkan Eftekhari,Rebekka V Jensen,Nicolaj B Støttrup,Jeppe G Rasmussen,Anders Junker,Svend E Jensen,Henrik S Hansen,Lisette O Jensen
BACKGROUND Target lesion failure (TLF) remains an issue with contemporary drug-eluting stents. The dual-therapy sirolimus-eluting and CD34 antibody-coated COMBO stent (DTS) was designed to improve early healing. AIMS We aimed to compare the 3-year outcomes of the DTS and the sirolimus-eluting Orsiro stent (SES) in all-comer patients treated with percutaneous coronary intervention. METHODS The SORT
-
Clinical outcomes following different stenting techniques for coronary bifurcation lesions: a systematic review and network meta-analysis of randomised controlled trials. EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Kamil Bujak,Filippo Maria Verardi,Victor Arevalos,Rami Gabani,Francesco Spione,Pawel Rajwa,Dejan Milasinovic,Goran Stankovic,Mariusz Gasior,Manel Sabaté,Salvatore Brugaletta
BACKGROUND Controversy still exists regarding the optimal treatment of coronary bifurcation lesions. AIMS We aimed to analyse the evidence from randomised controlled trials (RCTs) to compare outcomes following different bifurcation stenting techniques. METHODS We systematically searched for RCTs comparing different techniques published up to July 2022. We then conducted a pairwise meta-analysis to
-
First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle. EuroIntervention (IF 6.2) Pub Date : 2023-10-23 Paul Sorajja,Irakli Gorgorishvili,Marcus Burns,Ian Buysschaert,Philippe Debonnaire,Jan Van der Heyden,Nadira Hamid
-
The tip-in and rendezvous techniques in retrograde chronic total occlusion percutaneous coronary interventions. EuroIntervention (IF 6.2) Pub Date : 2023-12-04 Salman S Allana,Athanasios Rempakos,Spyridon Kostantinis,Michaella Alexandrou,Deniz Mutlu,Khaldoon Alaswad,Lorenzo Azzalini,Kathleen Kearney,Oleg Krestyaninov,Dmitrii Khelimskii,Sevket Gorgulu,Raj H Chandwaney,Farouc A Jaffer,Jaikirshan J Khatri,Rhian E Davies,Stewart M Benton,James W Choi,Dimitrios Karmpaliotis,Paul Poommipanit,William Nicholson,Wissam Jaber,Stephane Rinfret,Jarrod Frizzel,Taral Patel
-
Ultrasound guidance for transfemoral access in coronary procedures: an individual participant-level data metaanalysis from the femoral ultrasound trialist collaboration. EuroIntervention (IF 6.2) Pub Date : 2023-10-05 Marc-André d'Entremont,Sulaiman Alrashidi,Arnold H Seto,Phong Nguyen,Guillaume Marquis-Gravel,Mazen S Abu-Fadel,Craig Juergens,Pierre Tessier,Samuel Lemaire-Paquette,Laura Heenan,Elizabeth Skuriat,Jessica Tyrwhitt,Étienne L Couture,Simon Bérubé,Sanjit S Jolly
BACKGROUND Randomised controlled trials of ultrasound (US)-guided transfemoral access (TFA) for coronary procedures have shown mixed results. AIMS We aimed to compare US-guided versus non-US-guided TFA from randomised data in an individual participant-level data (IPD) meta-analysis. METHODS We completed a systematic review and an IPD meta-analysis of all randomised controlled trials comparing US-guided
-
UNICA - a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency. EuroIntervention (IF 6.2) Pub Date : 2023-10-02 Mohammad Sherif,Anja Schmidt,Jan Ragnar Path,Markus Rheinthaler,Tobias Daniel Trippel
-
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Ioannis T Farmakis,Stefano Barco,George Giannakoulas,Karsten Keller,Luca Valerio,Tobias Tichelbäcker,Sasan Partovi,Ingo Ahrens,Stavros V Konstantinides,Lukas Hobohm
BACKGROUND Reperfusion therapy is challenging in the elderly. Catheter-directed therapies are an alternative for higher-risk pulmonary embolism (PE) patients if systemic thrombolysis (ST) is contraindicated or has failed. Their safety has not been evaluated in specific vulnerable populations. AIMS We aimed to assess the safety of reperfusion therapies in elderly and frail patients in the real world
-
De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy. EuroIntervention (IF 6.2) Pub Date : 2023-12-04 Min Chul Kim,Sung Gyun Ahn,Kyung Hoon Cho,Doo Sun Sim,Young Joon Hong,Ju Han Kim,Myung Ho Jeong,Jun-Won Lee,Young-Jin Youn,Hee-Yeol Kim,Ki-Dong Yoo,Doo-Soo Jeon,Eun-Seok Shin,Young-Hoon Jeong,Kiyuk Chang,Youngkeun Ahn
BACKGROUND The benefits of de-escalation of P2Y12 inhibition after percutaneous coronary intervention (PCI) may differ by high bleeding risk (HBR) status. AIMS We investigated the efficacy and safety of de-escalation from ticagrelor to clopidogrel after PCI by HBR status. METHODS This is a non-prespecified post hoc analysis of the TicAgrelor Versus CLOpidogrel in Stabilized Patients with Acute Myocardial
-
Cerebral embolic protection during transcatheter heart interventions. EuroIntervention (IF 6.2) Pub Date : 2023-09-18 Victor Alfonso Jimenez Diaz,Samir R Kapadia,Axel Linke,Darren Mylotte,Alexandra J Lansky,Eberhard Grube,Magnus Settergren,Rishi Puri
Stroke remains a devastating complication of transcatheter aortic valve replacement (TAVR), with the incidence of clinically apparent stroke seemingly fixed at around 3% despite TAVR's significant evolution during the past decade. Embolic showers of debris (calcium, atheroma, valve material, foreign material) are captured in the majority of patients who have TAVR using a filter-based cerebral embolic
-
Learning the lessons (again) of the challenges of conducting sham-controlled device trials in hypertension. EuroIntervention (IF 6.2) Pub Date : 2023-09-18 Andrew S P Sharp,Ajay J Kirtane
-
Reconsidering the evidence for CTO PCI: the devil is in the detail. EuroIntervention (IF 6.2) Pub Date : 2023-09-18 Rasha K Al-Lamee,Sarosh A Khan,John Davies
-
DAPT guided by platelet function tests or genotyping after PCI: pros and cons. EuroIntervention (IF 6.2) Pub Date : 2023-09-18 Dominick J Angiolillo,Mattia Galli,Antonio Landi,Marco Valgimigli
-
Transcatheter aortic valve implantation: the shape matters. EuroIntervention (IF 6.2) Pub Date : 2023-09-18 Won-Keun Kim,Andreas Holzamer
-
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation. EuroIntervention (IF 6.2) Pub Date : 2023-09-18 Juan Pablo Sanchez-Luna,Pedro Martín,Antonio E Dager,Pablo D Charry,Javier R Beltrán,Ángel Sánchez-Recalde,Francesco Giannini,Antonio Gómez-Menchero,Manuel Pan,Alfonso Ielasi,Andrea Monastyrski,Marco Barbanti,Francisco Fernandez-Avilés,Marco Bruno Ancona,Abdurashid Mussayev,Juan Pablo De Brahi,Pablo Lamelas,Andrés Sánchez-Pérez,Melissa García Puerta,Miguel Ortiz,Jose Carlos Gonzalez-Gutiérrez,Giorgio
BACKGROUND Transcatheter aortic valve replacement (TAVR) in non-calcified aortic regurgitation (NCAR) is an off-label procedure. The balloon-expandable Myval includes extra-large sizes (30.5 mm and 32 mm) of interest in this setting. AIMS We aimed to evaluate the safety and feasibility of Myval in NCAR. METHODS This was an international, multicentre, observational study that enrolled all consecutive
-
Histological examination of renal nerve distribution, density, and function in humans. EuroIntervention (IF 6.2) Pub Date : 2023-09-18 Helge Struthoff,Lucas Lauder,Mathias Hohl,Alexander Hermens,Abraham Rami Tzafriri,Elazer R Edelman,Michael Kunz,Michael Böhm,Thomas Tschernig,Felix Mahfoud
BACKGROUND Renal denervation is optimised when guided by knowledge of nerve distribution. AIMS We aimed to assess sympathetic nerve distribution along the renal arteries, especially in post-bifurcation vessel segments. METHODS Renal arteries and surrounding tissue from 10 body donors were collected and examined histologically. Immunohistochemical staining was used to analyse nerve distribution and
-
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO). EuroIntervention (IF 6.2) Pub Date : 2023-09-18 Gerald S Werner,David Hildick-Smith,Victoria Martin Yuste,Nicolas Boudou,Georgios Sianos,Valery Gelev,Jose Ramon Rumoroso,Andrejs Erglis,Evald Hoj Christiansen,Javier Escaned,Carlo Di Mario,Luis Teruel,Alexander Bufe,Bernward Lauer,Alfredo Ruggero Galassi,Yves Louvard
BACKGROUND Percutaneous coronary intervention (PCI) for chronic total coronary occlusions (CTO) improves clinical symptoms and quality of life. The longer-term safety of PCI compared to optimal medical therapy (OMT) remains uncertain. AIMS We sought to evaluate the long-term safety of PCI for CTO in a randomised trial as compared to OMT. METHODS A total of 396 patients with a symptomatic CTO were enrolled
-
OCT guidance for evaluation and treatment of the long-term consequences of inadequate ostial left circumflex stenting. EuroIntervention (IF 6.2) Pub Date : 2023-12-04 Dejan Milasinovic,Salvatore Brugaletta,Dario Jelic,Goran Stankovic
-
Immediate and follow-up outcomes of drug-coated balloon angioplasty in de novo long lesions on large coronary arteries. EuroIntervention (IF 6.2) Pub Date : 2023-09-05 Pier Pasquale Leone,Angelo Oliva,Damiano Regazzoli,Mauro Gitto,Laura Novelli,Ottavia Cozzi,Giulio Giuseppe Stefanini,Marco Luciano Rossi,Alessandro Sticchi,Francesco Tartaglia,Antonio Mangieri,Bernhard Reimers,Antonio Colombo
-
Direct wire pacing for transcatheter mitral valve replacement. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Clément Servoz,Jérôme Wintzer-Wehekind,Jean-Michel Paradis,Didier Champagnac,Gaetan Charbonnier,Julio Farjat-Pasos,Mohamed Abdellaoui,Nicolas Dumonteil,Benjamin Faurie
-
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Daijiro Tomii,Taishi Okuno,Dik Heg,Masaaki Nakase,Jonas Lanz,Fabien Praz,Stefan Stortecky,David Reineke,Stephan Windecker,Thomas Pilgrim
BACKGROUND Both measured and predicted effective orifice area (EOA) indexed to the body surface area (EOAi) have been suggested to define prosthesis-patient mismatch (PPM) in patients undergoing transcatheter aortic valve replacement (TAVR). The impact of PPM on clinical outcomes may accumulate with extended follow-up and vary according to the definition used. AIMS We aimed to investigate the long-term
-
A novel device for atrial septal defect occlusion (GORE CARDIOFORM). EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Ines Hribernik,John Thomson,Amit Bhan,Michael Mullen,Patrick Noonan,Benjamin Smith,Niki Walker,Antigoni Deri,James Bentham
The GORE CARDIOFORM atrial septal defect (ASD) Occluder (GCA) is composed of a platinum-filled nitinol wire frame covered with expanded polytetrafluoroethylene, making it softer and more conformable compared with nitinol mesh devices. After the ASSURED clinical study confirmed the efficacy and safety of the device, it received U.S. Food and Drug Administration approval and a European conformity mark
-
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 Dirk Jan van Ginkel,Willem L Bor,Christophe L F Dubois,Hugo M Aarts,Maxim J P Rooijakkers,Kees H van Bergeijk,Liesbeth Rosseel,Leo Veenstra,Ole De Backer,Nicolas M Van Mieghem,Frank van der Kley,Adriaan Wilgenhof,Remigio Leonora,Jonathan Halim,Carl E Schotborgh,Emanuele Barbato,Jan A S Van Der Heyden,Peter Frambach,Bert Ferdinande,Darren Mylotte,Enrico Fabris,Benno J W M Rensing,Leo Timmers,Martin
About one-third of patients undergoing transcatheter aortic valve implantation (TAVI) use oral anticoagulants (OAC), mainly due to atrial fibrillation. General guidelines advise interrupting OAC in patients with a high risk of bleeding undergoing interventions. However, preliminary observational data suggest that the continuation of OAC during TAVI is safe and may reduce the risk of periprocedural
-
Mitral regurgitation improvement after TAVI: if well planned, two birds are killed with one stone. EuroIntervention (IF 6.2) Pub Date : 2023-08-21 José Luis Zamorano Gómez,Ana Pardo Sanz
-
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons. EuroIntervention (IF 6.2) Pub Date : 2023-08-21 Antonio L Bartorelli,Daniele Andreini,Gennaro Giustino,George Dangas
-
VA-ECMO in cardiogenic shock: is the road closed or open? EuroIntervention (IF 6.2) Pub Date : 2023-08-21 Holger Thiele,Anne Freund
-
Initial findings with the PATient experience in the CATH Lab (PATCATH) patient-reported experience metric. EuroIntervention (IF 6.2) Pub Date : 2023-12-04 Sean Fitzgerald,Hannah Wilson,Maureen Brenan,Himanshu Rai,Nicoletta Begossi,Nial Blake,Hugh McCann,Gavin Blake,Róisín Colleran,Colm G Hanratty,Robert A Byrne
-
Orthotopic stenting after BASILICA - an indicator of procedural success. EuroIntervention (IF 6.2) Pub Date : 2023-08-07 Toby Rogers,Christopher G Bruce
-
-
Quantitative flow ratio and cardiovascular risk: paralleling the FFR ischaemic continuum. EuroIntervention (IF 6.2) Pub Date : 2023-08-07 Morton J Kern
-
Redo-TAVI with SAPIEN 3 in SAPIEN XT or SAPIEN 3 - impact of pre- and post-dilatation on final THV expansion. EuroIntervention (IF 6.2) Pub Date : 2023-11-17 David Meier,Uri Landes,Lars Sondergaard,Ole De Backer,Georg Lutter,Thomas Puehler,Mariama Akodad,Georgios Tzimas,Philipp Blanke,Geoffrey W Payne,Althea Lai,Hacina Gill,David A Wood,John G Webb,Stephanie L Sellers,Janarthanan Sathananthan
BACKGROUND When a balloon-expandable transcatheter heart valve (THV) is chosen to treat a failed balloon-expandable THV, there is a risk of underexpansion with a potential impact on performance. AIMS We aimed to assess the impact of pre- and post-dilatation on the expansion of balloon-expandable THVs after redo-transcatheter aortic valve implantation (TAVI). METHODS Redo-TAVI was performed on the bench
-
First-in-human experience with a novel transcatheter direct annuloplasty system for severe atrial functional mitral regurgitation. EuroIntervention (IF 6.2) Pub Date : 2023-07-24 Zhong-Kai Zhu,Zhen-Gang Zhao,Ting-Chao Zhang,Fei Chen,Xin Wei,Yu-Jia Liang,Yuan Feng,Mao Chen
-
In-hospital initiation of PCSK9 inhibitors in ACS: pros and cons. EuroIntervention (IF 6.2) Pub Date : 2023-07-17 Konstantin A Krychtiuk,Marc J Claeys,Baris Gencer,François Mach